ExoRNA Bio
Latest round
- Angel
Last raised
- May 2023
Total raised
- Undisclosed
Investors
- 5
About ExoRNA Bio
Found in 2021 and based in Shanghai, China, ExoRNA Bio is a biotech company that focuses on the development of small RNA nucleic acid drugs, which was established by Chenyu Zhang and Xia Meng. The CSO and Founder, Chenyu Zhang, has over 15 years of research experience in various RNAs and published more than 300 papers in Nature, Science, Cell, and their subsidiaries. The CEO and Co-Founder, Xia Meng, graduated from the University of Paris VI and has published over 30 articles in Clinical Cancer Research, PNAS, and PLoS One. The company engages in the development of delivery platforms and related drugs. The company has a third-generation RNAi drug delivery platform in vivo. The third-generation RNAi drug delivery platform in vivo can cross the blood-brain barrier and overcome the treatment of CNS neurological diseases. Based on bioinformatics, statistics, AI, and gene databases, it has developed the Shengxin analysis platform that can promote the development of small nucleic acid drugs.
Who invested in ExoRNA Bio
5 investors across 2 rounds
See all investors in ExoRNA Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ExoRNA Bio
Who invested in ExoRNA Bio?
ExoRNA Bio has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ExoRNA Bio raised?
ExoRNA Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ExoRNA Bio last raise money?
ExoRNA Bio's most recent round on record is a Angel, in May 2023.
What does ExoRNA Bio do?
Found in 2021 and based in Shanghai, China, ExoRNA Bio is a biotech company that focuses on the development of small RNA nucleic acid drugs, which was established by Chenyu Zhang and Xia Meng.
Where is ExoRNA Bio headquartered?
ExoRNA Bio is headquartered in Shanghai, China.
Which VCs invest in companies like ExoRNA Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at ExoRNA Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like ExoRNA Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.